尿道狹窄治療市場：按類型、治療（尿道擴張、開放式尿道內切開術、尿道切開術、其他）、疾病適應症、最終用戶、地區 - 規模、份額、前景、機會分析，2023-2030 年

尿道狹窄是由於感染或受傷留下的疤痕導致的尿道狹窄。 尿道狹窄有兩種類型：後尿道狹窄和前尿道狹窄。 後尿道狹窄是由於後尿道纖維化、外傷挫傷或骨盆骨折所致。 前尿道狹窄是最常見的狹窄，由感染或外傷引起的海綿體纖維化引起。 這種情況可以通過多種治療方法進行治療，包括直接尿道鏡內尿道切開術 (DVIU) 和尿道成形術。 尿道狹窄的主要症狀是排尿受阻或刺激、排尿時間增加和膀胱排空不完全感。 它在發達國家男性中的患病率估計為 0.9%。 它可導致阻塞性和刺激性排尿症狀，並最終降低腎功能。 尿道狹窄可由泌尿科診斷和治療程序引起。 隨著人口老齡化的到來，這些手術變得越來越普遍，因此尿道狹窄也可能變得更加普遍。

市場動態

市場越來越多地採用監管批准等無機增長策略來擴大其產品組合，預計這將在預測期內推動市場增長。 例如，2022 年 1 月，Laborie.) 已宣布該產品已獲批。

這項研究的主要特點

• 本報告對全球尿道狹窄治療市場進行了深入分析，並展示了以 2022 年為基準年的預測期（2023-2030 年）的市場規模和復合年增長率 (CAGR%)。
• 它闡明了各個細分市場的潛在收入機會，並概述了該市場具有吸引力的投資建議矩陣。
• 它還提供有關市場驅動因素、制約因素、機會、新產品發布或批准、市場趨勢、區域前景以及主要參與者採用的競爭策略的重要見解。
• 根據公司亮點、產品組合、主要亮點、財務業績和戰略等參數，介紹全球尿道狹窄治療市場的主要參與者概況。
• 本研究涵蓋的主要公司包括 Becton、Dickinson and Company、Amecath、Zhejiang Chuangxiang、Medical Technology Co., Ltd.、Allium Ltd.、SURGIMEDIK、Cook Group、Taewoong Medical Co., Ltd.、Teleflex Incorporated、 B. Braun Melsungen AG、Coloplast A/S、Boston Scientific Corporation 和 Pnn Medical A/S.，以及 Laborie。這份報告的見解將使營銷人員和公司的管理當局能夠就其未來的產品發布做出明智的決定，類型升級、市場擴張和營銷策略。
• 《全球尿道狹窄治療市場》報告面向該行業的各種利益相關者，包括投資者、供應商、產品製造商、分銷商、新進入者和金融分析師。
• 利益相關者可以通過用於分析全球尿道狹窄治療市場的各種戰略矩陣來促進他們的決策。

內容

第 1 章目的和先決條件

• 調查目的
• 先決條件
• 縮寫

第二章市場展望

• 報告概述
  • 市場定義和範圍
• 執行摘要
  • 市場概況，按類型
  • 市場概況：按療法分類
  • 市場概況：按疾病適應症分類
  • 市場概況：按最終用戶分類
  • 市場概況：按地區
• 連貫機會圖 (COM)

第3章市場動態、規律及趨勢分析

• 市場動態
  • 司機
  • 約束因素
  • 市場機會
  • 影響分析
  • 主要亮點
  • 產品發布
  • 技術進步
  • 害蟲分析
  • 監管情景
  • 併購

第 4 章全球尿道狹窄治療市場 - 冠狀病毒 (COVID-19) 大流行的影響

• 經濟影響
• 關於 COVID-19 的流行病學
• 對供需的影響

第 5 章全球尿道狹窄治療市場，按類型，2017-2030

• 後尿道狹窄
• 前尿道狹窄

第 6 章全球尿道狹窄治療市場，按治療方法，2017-2030

• 尿道擴張
• 直視內尿道切開術 (DVIU)
• 尿道成形術
• 尿道吻合術
• 置換尿道成形術
• 其他

第 7 章全球尿道狹窄治療市場，按疾病適應症，2017-2030

• 醫源性
• 特發性
• 源自傳染病
• 創傷
• 其他

第 8 章全球尿道狹窄治療市場：按最終用戶分類，2017-2030

• 醫院
• 門診手術中心
• 其他

第 9 章全球尿道狹窄治療市場：地區，2017-2030

• 北美
• 美國
• 加拿大
• 拉丁美洲
• 巴西
• 墨西哥
• 阿根廷
• 其他拉丁美洲
• 歐洲
• 英國
• 德國
• 意大利
• 法國
• 西班牙
• 俄羅斯
• 其他歐洲
• 亞太地區
• 中國
• 印度
• 日本
• 東盟
• 澳大利亞
• 韓國
• 其他亞太地區
• 中東
• 海灣合作委員會
• 以色列
• 其他中東地區
• 非洲
• 北非
• 中非
• 南非

第10章競爭格局

• Becton, Dickinson and Company
• Amecath
• Zhejiang Chuangxiang Medical Technology Co., Ltd
• Allium Ltd.
• SURGIMEDIK
• Cook Group
• Teawoong Medical Co., Ltd.
• Teleflex Incorporated
• B. Braun Melsungen AG
• Coloplast A/S
• Boston Scientific Corporation
• Pnn Medical A/S
• Laborie.

第 11 章章節

• 調查方法
• 關於出版商

Urethral stricture is the narrowing of the calibre of the urethra that is caused due to scarring resulting from infection or injury. There are two types of urethral strictures named posterior urethral stricture and anterior urethral stricture. Posterior urethral strictures occur due to fibrosis of the posterior urethra or distraction injuries that result from trauma or pelvic fractures. Anterior urethral stricture are the most commonly occurring strictures, and are caused due to infection or trauma leading to spongiofibrosis. The condition can be treated with various treatment options such as urethral direct vision internal urethrotomy (DVIU), urethroplasty, and other treatments. The main symptoms of urethral stricture are obstructed and irritated micturition, with increased urination time, and a feeling of incomplete bladder emptying. Its prevalence among men in industrial countries is estimated at 0.9%. It produces obstructive and irritative urinary symptoms, and can ultimately impair renal function. Urethral strictures can be caused by diagnostic or therapeutic urological procedures. These procedures are being performed more commonly, because the population is aging, and thus, urethral strictures will probably become more common as well.

Market Dynamics

Increasing adoption of inorganic growth strategies such as approvals by the regulatory authorities in the market to expand their product portfolio, is expected to drive the market growth over the forecast period. For instance, in January 2022, Laborie., a medical technology company thath provide products for urology, gynecology, and others, announced that it has received a license to the Optilume, a urethral drug coated balloon (DCB), laborite., and product is approved from U.S. Food and Drug Administration (FDA).

Key features of the study:

• This report provides in-depth analysis of the global urethral stricture treatment market, and provides market size (US$ Million) and Compound Annual Growth Rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global urethral stricture treatment market based on the following parameters-company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study are Becton, Dickinson and Company, Amecath, Zhejiang Chuangxiang, Medical Technology Co., Ltd, Allium Ltd., SURGIMEDIK, Cook Group, Taewoong Medical Co., Ltd., Teleflex Incorporated, B. Braun Melsungen AG, Coloplast A/S, Boston Scientific Corporation, and Pnn Medical A/S. , and Laborie.Insights from this report will allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global urethral stricture treatrment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global urethral stricture treatment market

Detailed Segmentation:

• Global Urethral Stricture Treatment Market, By Type:
  • Posterior Urethral Stricture
  • Anterior Urethral Stricture
• Global Urethral Stricture Treatment Market, By Treatment:
  • Urethral Dilation
  • Direct Vision Internal Urethrotomy (DVIU)
  • Urethroplasty
    • Anastomotic Urethroplasty
    • Substitution Urethroplasty
  • Others
• Global Urethral Stricture Treatment Market, By Disease Indication:
  • Latrogenic
  • Idiopathic
  • Infection-induced
  • Trauma
  • Others
• Global Urethral Stricture Treatment Market, By End User:
  • Hospitals
  • Ambulatory Surgical Centers
  • Others
• Global Urethral Stricture Treatment Market, By Region:
  • North America
    • By Country:
  • U.S.
  • Canada
  • Latin America
    • By Country:
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
    • By Country:
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • By Country
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
    • By Country:
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • By Country/Region:
  • South Africa
  • Central Africa
  • North Africa
• Company Profiles
  • Becton, Dickinson and Company*
    • Company Highlights
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Amecath
  • Zhejiang Chuangxiang
  • Medical Technology Co., Ltd
  • Koninklijke Philips N.V.
  • Allium Ltd.
  • SURGIMEDIK
  • Cook Group
  • Taewoong Medical Co., Ltd.
  • Teleflex Incorporated
  • Braun Melsungen AG
  • Coloplast A/S
  • Boston Scientific Corporation
  • Pnn Medical A/S

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Type
  • Market Snapshot, By Treatment
  • Market Snapshot, By Disease Indication
  • Market Snapshot, By End User
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
  • Impact Analysis
  • Key Highlights
  • Product Launches
  • Technological Advancements
  • PEST Analysis
  • Regulatory Scenario
  • Mergers and Acquisitions

4. Global Urethral Stricture Treatment Market- Impact of Coronavirus (Covid-19) Pandemic

• Economic Impact
• COVID-19 Epidemiology
• Impact on Supply and Demand

5. Global Urethral Stricture Treatment Market, By Type, 2017-2030, (US$ Million)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Posterior Urethral Stricture
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Anterior Urethral Stricture
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

6. Global Urethral Stricture Treatment Market, By Treatment, 2017 - 2030, (US$ Million)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Urethral Dilation
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Direct Vision Internal Urethrotomy (DVIU)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Urethroplasty
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Anastomotic Urethroplasty
  • Introduction
  • Market Size and Forecast, and Y-O-Y Growth, 2017-2030, (US$ Million)
• Substitution Urethroplasty
  • Introduction
  • Market Size and Forecast, and Y-O-Y Growth, 2017-2030, (US$ Million)
• Others
  • Introduction
  • Market Size and Forecast, and Y-O-Y Growth, 2017-2030, (US$ Million)

7. Global Urethral Stricture Treatment Market, By Disease Indication, 2017 - 2030, (US$ Million)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segments Trends
• Latrogenic
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Idiopathic
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Infection-induced
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Trauma
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Others
  • Introduction
  • Market Size and Forecast, and Y-O-Y Growth, 2017-2030, (US$ Million)

8. Global Urethral Stricture Treatment Market, By End User, 2017 - 2030, (US$ Million)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-O-Y Growth analysis, 2017 - 2030
  • Segment Trends
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-O-Y Growth, 2017 - 2030, (US$) Million)
• Ambulatory Surgical Centers
  • Introduction
  • Market Size and Forecast, and Y-O-Y Growth, 2017 - 2030, (US$) Million)
• Others
  • Introduction
  • Market Size and Forecast, and Y-O-Y Growth, 2017 - 2030, (US$) Million)

9. Global Urethral Stricture Treatment Market, By Region, 2017 - 2030, (US$ Million)

• Introduction
  • Market Share Analysis, By Region, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, For Region, 2017-2030
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• U.S.
• Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• U.K.
• Germany
• Italy
• France
• Spain
• Russia
• Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• China
• India
• Japan
• ASEAN
• Australia
• South Korea
• Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• GCC
• Israel
• Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 - 2030, (US$ Million)
• North Africa
• Central Africa
• South Africa

10. Competitive Landscape

• Becton, Dickinson and Company
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Amecath
• Zhejiang Chuangxiang Medical Technology Co., Ltd
• Allium Ltd.
• SURGIMEDIK
• Cook Group
• Teawoong Medical Co., Ltd.
• Teleflex Incorporated
• B. Braun Melsungen AG
• Coloplast A/S
• Boston Scientific Corporation
• Pnn Medical A/S
• Laborie.

11. Section

• Research Methodology
• About Us